Profile
David Nikodem currently works at AltheaDx, Inc., as Chief Executive Officer & Director from 2018 and Sapidus Consulting Group LLC, as Member.
Dr. Nikodem also formerly worked at BNP Paribas Securities Corp., as Director from 2005 to 2007, Alzheon, Inc., as Independent Director, Tunitas Therapeutics, Inc., as Director, CG Oncology, Inc., as Director, Blumberg Capital Management LLC, as Analyst from 2002 to 2005, Exane Asset Management SA, as Portfolio Manager, and Inventiva SA, as Vice President-US Operations.
Dr. Nikodem received his undergraduate degree from the University of Virginia and doctorate degree from Georgetown University.
David Nikodem active positions
| Companies | Position | Start |
|---|---|---|
| ALTHEADX INC | Chief Executive Officer | 2018-11-30 |
Sapidus Consulting Group LLC | Corporate Officer/Principal | - |
Former positions of David Nikodem
| Companies | Position | End |
|---|---|---|
BNP Paribas Securities Corp.
BNP Paribas Securities Corp. Investment Banks/BrokersFinance Provides brokerage services | Trading-Equity | 2007-12-29 |
Blumberg Capital Management LLC
Blumberg Capital Management LLC Investment ManagersFinance Blumberg focuses on investments in the life sciences sector. | Analyst-Equity | 2005-08-30 |
| INVENTIVA | Corporate Officer/Principal | - |
Tunitas Therapeutics, Inc.
Tunitas Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics for the treatment of allergy | Director/Board Member | - |
| CG ONCOLOGY, INC. | Director/Board Member | - |
Education of David Nikodem
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
BNP Paribas Securities Corp.
BNP Paribas Securities Corp. Investment Banks/BrokersFinance Provides brokerage services | Finance |
AltheaDx, Inc.
AltheaDx, Inc. Medical SpecialtiesHealth Technology Operates as a commercial stage molecular diagnostics company | Health Technology |
Alzheon, Inc.
Alzheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for neurodegenerative disorders | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blumberg Capital Management LLC
Blumberg Capital Management LLC Investment ManagersFinance Blumberg focuses on investments in the life sciences sector. | Finance |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exane Asset Management SA
Exane Asset Management SA Investment ManagersFinance Exane AM is an active, conviction-based manager which specializes in stock-picking within the European equity investment universe. The firm selects securities based on a fundamental approach combining stock-picking and macroeconomic analysis. For long/short equity they cumulate buy positions with short sale positions in equities, resulting in low correlation to equity indexes. | Finance |
Tunitas Therapeutics, Inc.
Tunitas Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics for the treatment of allergy | Health Technology |
CG Oncology, Inc.
CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic | Health Technology |
Inventiva SA
Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
Sapidus Consulting Group LLC |
- Stock Market
- Insiders
- David Nikodem
















